Delivery Order SPE2DB20D3103-SPE2DB25FP5R0
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,333,801 units of the pharmaceutical product Nifedipine ER 60 mg tablets, with a firm fixed price ceiling value of $1,109.10. The delivery order has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $85,120 to Amerisourcebergen Drug Corporation for the supply of 100 boxes of 90mg Nifedipine ER tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by June 23, 2023. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen Drug Corporation, the prime...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,564,322,407 units of the pharmaceutical product Nisoldipine ER 30 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $1,509.86 and an ultimate completion date of April 19, 2024. This order is placed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,313.95 to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units). This firm fixed-price delivery order, awarded on July 18, 2025, was completed by July 21, 2025, with no set-aside designation applied. The award utilizes a competitive procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. Performance of this...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,885.87 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of 500 units of 145 mg Fenofibrate tablets to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,749.60 contract is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic categories such as diabetes, neurology, pain management, and specialty pharmaceuticals. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,853.68, is for the supply of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a $571,727.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic domains such as diabetes, neurology, pain management, and more. This delivery order is part of a larger $999,999,999.00 Indefinite...
- This delivery order, valued at $17,808.55, was awarded to AmerisourceBergen Drug Corp on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract represents a non-compete, firm fixed-price delivery order for pharmaceutical and medical supply products to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, and pain management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5R0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,102.76 to AmerisourceBergen Drug Corp for the supply of Nifedipine ER 30 mg tablets (100-count units), with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contractor is based in Conshohocken, Pennsylvania, which also serves as the place of performance for this pharmaceutical supply contract. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company's IDC with the DLA enables it to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/18/25 |